Efficacy of N-Acetylcysteine in Improving/Normalizing ALT & AST in Patients of NAFLD

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
Currently researches are focusing on the effect of antioxidants in the treatment of non-alcoholic fatty liver disease (NAFLD). Since N-acetyl cysteine (NAC) has been proven to have antioxidant and anti-inflammatory properties, therefore, we will conduct this study to determine the effect of NAC in patients of NAFLD with raised liver enzymes.
Epistemonikos ID: 71c743d9d037838b73581d2a1ec1b43419fd068f
First added on: May 14, 2024